Feedback / Questions
BND-22 - Biond Biologics, Sanofi
Libtayo (cemiplimab-rwlc) - Regeneron
http://clinicaltrials.gov/ct2/show/NCT06651593
Oct 21, 2024
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next